Zoe A Stephenson
Identification of a novel toxicophore in anti-cancer chemotherapeutics that targets mitochondrial respiratory complex I
Stephenson, Zoe A; Harvey, Robert F; Pryde, Kenneth R; Mistry, Sarah; Hardy, Rachel E; Serreli, Riccardo; Chung, Injae; Allen, Timothy EH; Stoneley, Mark; MacFarlane, Marion; Fischer, Peter M; Hirst, Judy; Kellam, Barrie; Willis, Anne E
Authors
Robert F Harvey
Kenneth R Pryde
Sarah Mistry
Rachel E Hardy
Riccardo Serreli
Injae Chung
Timothy EH Allen
Mark Stoneley
Marion MacFarlane
Peter M Fischer
Judy Hirst
BARRIE KELLAM BARRIE.KELLAM@NOTTINGHAM.AC.UK
Professor of Medicinal Chemistry
Anne E Willis
Abstract
Disruption of mitochondrial function selectively targets tumour cells that are dependent on oxidative phosphorylation. However, due to their high energy demands, cardiac cells are disproportionately targeted by mitochondrial toxins resulting in a loss of cardiac function. An analysis of the effects of mubritinib on cardiac cells showed that this drug did not inhibit HER2 as reported, but directly inhibits mitochondrial respiratory complex I, reducing cardiac-cell beat rate, with prolonged exposure resulting in cell death. We used a library of chemical variants of mubritinib and showed that modifying the 1H-1,2,3-triazole altered complex I inhibition, identifying the heterocyclic 1,3-nitrogen motif as the toxicophore. The same toxicophore is present in a second anti-cancer therapeutic carboxyamidotriazole (CAI) and we demonstrate that CAI also functions through complex I inhibition, mediated by the toxicophore. Complex I inhibition is directly linked to anti-cancer cell activity, with toxicophore modification ablating the desired effects of these compounds on cancer cell proliferation and apoptosis.
Citation
Stephenson, Z. A., Harvey, R. F., Pryde, K. R., Mistry, S., Hardy, R. E., Serreli, R., …Willis, A. E. (2020). Identification of a novel toxicophore in anti-cancer chemotherapeutics that targets mitochondrial respiratory complex I. eLife, 9, Article e55845. https://doi.org/10.7554/elife.55845
Journal Article Type | Article |
---|---|
Acceptance Date | May 20, 2020 |
Online Publication Date | May 20, 2020 |
Publication Date | May 20, 2020 |
Deposit Date | Jun 16, 2020 |
Publicly Available Date | Jun 16, 2020 |
Journal | eLife |
Publisher | eLife Sciences Publications |
Peer Reviewed | Peer Reviewed |
Volume | 9 |
Article Number | e55845 |
DOI | https://doi.org/10.7554/elife.55845 |
Keywords | General Biochemistry, Genetics and Molecular Biology; General Immunology and Microbiology; General Neuroscience; General Medicine |
Public URL | https://nottingham-repository.worktribe.com/output/4501163 |
Publisher URL | https://elifesciences.org/articles/55845 |
Files
Identification of a novel toxicophore in anti-cancer chemotherapeutics that targets mitochondrial respiratory complex I
(1.6 Mb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
You might also like
Optimization of Peptide Linker-Based Fluorescent Ligands for the Histamine H1 Receptor
(2022)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: digital-library-support@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search